The abstract is read at the publisher; the summary is JClub's.
Most disease-associated KCNH1 variants (26 total) show gain-of-function features—hyperpolarized activation voltage and/or faster activation—shifting resting membrane potential more hyperpolarized.
- Why it matters: Understanding how KCNH1 variants alter channel behavior is needed to clarify molecular mechanisms in Temple-Baraitser syndrome, Zimmermann-Laband syndrome, epileptic encephalopathy, and related neurodevelopmental disorders.
- What they did: Using automated patch clamp, the study tested 26 KCNH1 variants in heterologous expression in homozygous and clinically relevant heterozygous co-expression with WT, plus effects of alternative splice isoforms and pharmacology with imipramine and LY97241.
- The result: One autism-cohort variant instead showed depolarized activation voltage dependence and a depolarized resting potential, while drug potency differences for imipramine and LY97241 suggest variant-specific therapeutic repurposing opportunities.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.